Immunotherapy Outcomes in Advanced Melanoma in Relation to Age.

The Permanente journal(2020)

引用 6|浏览14
暂无评分
摘要
Aging does not seem to affect response to checkpoint inhibitors. Elderly patients with metastatic melanoma should be treated similarly to younger patients.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要